Although macrophage migration inhibitory factor (MIF) was originally identi®ed as a lymphokine that inhibits the migration of macrophages, its ubiquitous expression suggests it may have a role beyond the immune system. Here we report a detailed characterization of MIF expression during mouse embryogenesis. The MIF expression pattern was found to parallel tissues speci®cation and organogenesis. q
Results

Macrophage migration inhibitory factor is expressed in multiple tissues during organogenesis
Macrophage migration inhibitory factor (MIF) is a multifunctional molecule which has been associated with many biological activities as a cytokine, as a hormone (Bucala, 1994) , and as an enzyme (Rosengren et al., 1996) . MIF expression has been reported in several adult tissues (Wistow et al., 1993; Nishino et al., 1995; Imamura et al., 1996; Nishibori et al., 1996) , suggesting broader functions. Although MIF expression is identi®ed in the early stages of murine embryos by RT-PCR and in the brain of rat embryos (Suzuki et al., 1999) , its spatial and temporal expression pattern during embryogenesis has not been well studied. We report here a detailed characterization of MIF expression pattern during embryogenesis which suggests the involvement of MIF in the development of various tissues. MIF mRNA was detected in somites, precartilage primordia in ribs and vertebrae, and branchial arches (Fig. 1a±e,g,i±k) . Somitogenesis commences at E8 and continues to E14, following a rostral-to-caudal gradient of differentiation. MIF expression was observed in somites by whole-mount in situ hybridization from E8.5 (Fig. 1a± e,i±k). As the number of somites increased, MIF expression was more prominent in caudal somites. Mesenchymal cells of ventral medial cell origin initiate differentiation at E11± E11.5 and ultimately form the cartilage of vertebrae and ribs. MIF was identi®ed in primordia of these cartilages at E11.5 and E12.5 (Fig. 1g,s) . MIF expression began at E9.5 in branchial arches with uniform distribution (Fig. 1b) . At E10.5, stronger expression was seen on the oral region of the maxillary and mandibular components of ®rst branchial arch, and this pattern became more prominent at E11.5 (Fig. 1e,g ). MIF expression began to appear in limb buds with uniform distribution when mesenchymal cells accumulated to form the primordium of limb buds at E9.5±E10.5 (Fig. 1b,e) . MIF expression was also observed in neural tissues, including forebrain, midbrain, hindbrain, neural tube, cranial ganglia, and dorsal root ganglia during all of the embryonic stages (Fig. 1a±c ,e±g,i,j,l±r). MIF expression in dorsal root ganglia progressed in a rostal-to-caudal pattern at E10.5±E11.5 similar to the expression seen in somites. Optic and otic vesicles also expressed MIF from E9.5 (Fig. 1b ,e,f,g). 
Onset of MIF expression coincides with the speci®cation of tissues
MIF expression was apparent in many embryonic tissues with a few exceptions of lung, spleen and thymus. The onset of MIF expression coincides with the speci®-cation of tissues during organogenesis and continued through adulthood. From E9.5 to E11.5, the liver primordium consists of loose, undifferentiated mesenchymal tissue. At E10.5 invasion of the mesenchyme by the hepatic cells of ventral endoderm and hematopoietic activity are initiated. Overt MIF expression was not detectable in E9.5±E11.5 day embryos (Fig. 2a) . MIF expression became apparent in a few cells at E12.5, when functional hepatic parenchymal cells appear in this region and steadily increased with developmental stages (Fig. 2a) . MIF-expressing cells are square-shaped with large cytoplasm, suggesting these cells are hepatocytes. MIF expression began to appear in metanephric tubules when tubulogenesis was initiated at E14.5 (Fig.  2b) . After E15 day, epithelial cells in convoluted tubules continuously expressed MIF. However, MIF was not detected in glomeruli in embryos or in adults. MIF began to appear in seminiferous epithelium at E12.5 when mesonephros is replaced by testicular tissue and was produced continuously during subsequent embryonic stages (Fig. 2c) . Such expression pattern is also seen in skin, intestine, adrenal gland, pancreas, salivary gland and nervous system (data not shown). The comparison of expression pro®les generated using immunohistochemistry with those of in situ hybridization showed similar expression pattern.
MIF is expressed during myogenesis
MIF expression was observed in all muscle cell types, including cardiac, smooth, and skeletal muscle, during embryonic development (Fig. 2d±f) . Continuous expression of MIF from E9.5 till birth was seen in cardiac muscle and a relatively low level was observed in 2-week-old mice (Fig.  2d,e) . Similarly, MIF was expressed prominently in skeletal and smooth muscle during embryogenesis (Fig. 2f) and relatively lower expression was observed in adult (data not shown).
Materials and methods
Immunohistochemical analysis of MIF
Immunohisto-and immunocytochemical analyses were carried out as described (Satornura et al., 1991) .
In situ hybridization for MIF mRNA
In situ hybridization was performed using the SureSitewII system Kit (Novagen, Madison, WI) following manufacturer's instructions. Whole-mount in situ analysis was carried out as described (Riddle et al., 1993) . Embryos were frozen in OCT compound and sectioned at 15±50 mm thickness.
